-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
- Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.63M, a 104% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $6.15M, a 77.1% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6.15M, a 77.1% increase from 2023.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.47M, a 39.3% decline from 2022.
- Corbus Pharmaceuticals Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.72M, a 39.7% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)